Sonexai Kidoikhammouan
Khon Kaen, 40002, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Integrated transcriptomic and molecular docking analysis identifies Rhotekin 2 as a promising therapeutic target for overcoming gemcitabine resistance in cholangiocarcinoma.
Journal: Biomedical reports
Published: June 17, 2025
Molecular Mechanisms of Gemcitabine Resistance in Cholangiocarcinoma.
Journal: Oncology research
Published: June 12, 2025
Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma.
Journal: Anticancer research
Published: October 03, 2024
Bioinformatics analysis identified TCP1 and NOTCH1 as potential target molecules to overcome 5-fluorouracil resistance in cholangiocarcinoma.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: September 26, 2024
Anti-Tumor and Chemosensitizing Effects of the CDK Inhibitor Dinaciclib on Cholangiocarcinoma In Vitro and In Vivo.
Journal: In vivo (Athens, Greece)
Published: April 17, 2024
Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insight.
Journal: Biochimica et biophysica acta. General subjects
Published: July 01, 2023
Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma.
Journal: Journal of cancer research and therapeutics
Published: March 19, 2019
Assessing skin disease and associated health-related quality of life in a rural Lao community.
Journal: BMC dermatology
Published: July 30, 2018
TNP-470, a methionine aminopeptidase-2 inhibitor, inhibits cell proliferation, migration and invasion of human cholangiocarcinoma cells in vitro.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 01, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026